track name="Histone (@ SK-MEL-2) 500" url="http://chip-atlas.org/view?id=$$" gffTags="on"
chr1 1550920 1551117 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 866 . 1550920 1551117 255,136,0
chr1 3817561 3817808 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 550 . 3817561 3817808 51,255,0
chr1 8021813 8021958 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 537 . 8021813 8021958 37,255,0
chr1 10093265 10093434 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 578 . 10093265 10093434 79,255,0
chr1 15851130 15851294 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 785 . 15851130 15851294 255,219,0
chr1 16840801 16841006 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 1000 . 16840801 16841006 255,0,0
chr1 16939842 16940032 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 820 . 16939842 16940032 255,183,0
chr1 16970980 16971133 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 552 . 16970980 16971133 53,255,0
chr1 16971305 16971503 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 713 . 16971305 16971503 217,255,0
chr1 16993470 16993657 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 1000 . 16993470 16993657 255,0,0
chr1 17066779 17066986 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 1000 . 17066779 17066986 255,0,0
chr1 17222261 17222446 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 1000 . 17222261 17222446 255,0,0
chr1 17231473 17231663 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 1000 . 17231473 17231663 255,0,0
chr1 17240754 17240926 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 635 . 17240754 17240926 137,255,0
chr1 19578080 19578236 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 776 . 19578080 19578236 255,228,0
chr1 22352066 22352304 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 628 . 22352066 22352304 130,255,0
chr1 26799012 26799286 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 708 . 26799012 26799286 212,255,0
chr1 27248295 27248486 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 702 . 27248295 27248486 206,255,0
chr1 28844823 28844980 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 569 . 28844823 28844980 70,255,0
chr1 29508053 29508325 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 617 . 29508053 29508325 119,255,0
chr1 32110258 32110446 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 673 . 32110258 32110446 176,255,0
chr1 32479540 32479703 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 582 . 32479540 32479703 83,255,0
chr1 32538617 32538775 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 652 . 32538617 32538775 155,255,0
chr1 32645356 32645502 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 602 . 32645356 32645502 104,255,0
chr1 36023086 36023245 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 828 . 36023086 36023245 255,175,0
chr1 36396373 36396586 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 625 . 36396373 36396586 127,255,0
chr1 41157441 41157717 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 531 . 41157441 41157717 31,255,0
chr1 43282839 43282996 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 650 . 43282839 43282996 153,255,0
chr1 43814936 43815103 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 608 . 43814936 43815103 110,255,0
chr1 44412409 44412551 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 607 . 44412409 44412551 109,255,0
chr1 45285708 45285864 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 743 . 45285708 45285864 247,255,0
chr1 52499238 52499385 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 530 . 52499238 52499385 30,255,0
chr1 53163802 53163966 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 603 . 53163802 53163966 105,255,0
chr1 53686081 53686256 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 906 . 53686081 53686256 255,95,0
chr1 54304035 54304204 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 897 . 54304035 54304204 255,105,0
chr1 62902508 62902655 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 604 . 62902508 62902655 106,255,0
chr1 63249544 63249695 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 646 . 63249544 63249695 148,255,0
chr1 63833426 63833597 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 624 . 63833426 63833597 126,255,0
chr1 70820186 70820342 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 536 . 70820186 70820342 36,255,0
chr1 75198916 75199107 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 616 . 75198916 75199107 118,255,0
chr1 90460763 90460909 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 540 . 90460763 90460909 40,255,0
chr1 91852840 91853070 ID=SRX2537511;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM2476352:%20NRAS%20metastatic%20melanoma%20ChIP-H3K27ac%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K27ac%20(Abcam,%20ab177178); 518 . 91852840 91853070 18,255,0
chr1 92764304 92764482 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 565 . 92764304 92764482 66,255,0
chr1 93297659 93297802 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 563 . 93297659 93297802 64,255,0
chr1 101491503 101491655 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 508 . 101491503 101491655 8,255,0
chr1 107599403 107599853 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 578 . 107599403 107599853 79,255,0
chr1 108742550 108742820 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 539 . 108742550 108742820 39,255,0
chr1 109234995 109235150 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 680 . 109234995 109235150 183,255,0
chr1 109289368 109289862 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 600 . 109289368 109289862 102,255,0
chr1 109633408 109633567 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 628 . 109633408 109633567 130,255,0
chr1 109642860 109643231 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 778 . 109642860 109643231 255,226,0
chr1 110026632 110026779 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 591 . 110026632 110026779 92,255,0
chr1 110091289 110091462 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 646 . 110091289 110091462 148,255,0
chr1 110950063 110950256 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 752 . 110950063 110950256 255,252,0
chr1 111506335 111506505 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 599 . 111506335 111506505 100,255,0
chr1 112297905 112298101 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 563 . 112297905 112298101 64,255,0
chr1 113161515 113161700 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 681 . 113161515 113161700 184,255,0
chr1 115259054 115259312 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 528 . 115259054 115259312 28,255,0
chr1 115300267 115300559 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 898 . 115300267 115300559 255,104,0
chr1 115323043 115323256 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 780 . 115323043 115323256 255,224,0
chr1 117664585 117664750 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 692 . 117664585 117664750 195,255,0
chr1 117909034 117909329 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 662 . 117909034 117909329 165,255,0
chr1 119683070 119683216 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 571 . 119683070 119683216 72,255,0
chr1 121484314 121485432 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 1000 . 121484314 121485432 255,0,0
chr1 121484344 121485417 ID=SRX2537511;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM2476352:%20NRAS%20metastatic%20melanoma%20ChIP-H3K27ac%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K27ac%20(Abcam,%20ab177178); 1000 . 121484344 121485417 255,0,0
chr1 121484376 121485418 ID=SRX2537505;Name=H3K4me1%20(@%20SK-MEL-2);Title=GSM2476346:%20NRAS%20metastatic%20melanoma%20ChIP-H3K4me1%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K4me1%20(Abcam,%20ab8895); 1000 . 121484376 121485418 255,0,0
chr1 142618879 142619164 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 693 . 142618879 142619164 196,255,0
chr1 142890584 142890912 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 577 . 142890584 142890912 78,255,0
chr1 144593739 144593926 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 541 . 144593739 144593926 41,255,0
chr1 144932241 144932413 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 615 . 144932241 144932413 117,255,0
chr1 145139333 145139557 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 544 . 145139333 145139557 44,255,0
chr1 145969481 145969622 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 521 . 145969481 145969622 21,255,0
chr1 147993934 147994075 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 560 . 147993934 147994075 61,255,0
chr1 151043301 151043512 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 520 . 151043301 151043512 20,255,0
chr1 153606605 153606773 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 504 . 153606605 153606773 4,255,0
chr1 153631221 153631368 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 598 . 153631221 153631368 99,255,0
chr1 154909250 154909393 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 585 . 154909250 154909393 86,255,0
chr1 154934302 154934465 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 814 . 154934302 154934465 255,189,0
chr1 155532795 155532946 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 684 . 155532795 155532946 187,255,0
chr1 155658648 155658792 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 611 . 155658648 155658792 113,255,0
chr1 156308380 156308527 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 576 . 156308380 156308527 77,255,0
chr1 157108458 157108639 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 514 . 157108458 157108639 14,255,0
chr1 161123793 161123955 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 655 . 161123793 161123955 158,255,0
chr1 161359471 161359675 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 564 . 161359471 161359675 65,255,0
chr1 161410880 161411073 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 701 . 161410880 161411073 205,255,0
chr1 161417191 161417341 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 581 . 161417191 161417341 82,255,0
chr1 161417664 161417987 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 541 . 161417664 161417987 41,255,0
chr1 161424579 161424723 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 597 . 161424579 161424723 98,255,0
chr1 161425009 161425348 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 561 . 161425009 161425348 62,255,0
chr1 161431979 161432149 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 624 . 161431979 161432149 126,255,0
chr1 161432447 161432762 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 572 . 161432447 161432762 73,255,0
chr1 161439346 161439522 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 770 . 161439346 161439522 255,234,0
chr1 161439824 161440152 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 683 . 161439824 161440152 186,255,0
chr1 161440509 161440661 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 557 . 161440509 161440661 58,255,0
chr1 161719629 161719984 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 559 . 161719629 161719984 60,255,0
chr1 167683741 167683905 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 682 . 167683741 167683905 185,255,0
chr1 179851454 179851607 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 652 . 179851454 179851607 155,255,0
chr1 200638815 200639005 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 604 . 200638815 200639005 106,255,0
chr1 201798381 201798634 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 560 . 201798381 201798634 61,255,0
chr1 203830787 203830950 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 617 . 203830787 203830950 119,255,0
chr1 218458305 218458450 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 517 . 218458305 218458450 17,255,0
chr1 228353513 228353672 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 605 . 228353513 228353672 107,255,0
chr1 228674838 228674980 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 614 . 228674838 228674980 116,255,0
chr1 234509261 234509403 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 514 . 234509261 234509403 14,255,0
chr1 236260396 236260722 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 1000 . 236260396 236260722 255,0,0
chr1 242011251 242011405 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 737 . 242011251 242011405 241,255,0
chr1 249200493 249200659 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 680 . 249200493 249200659 183,255,0
chr10 3441633 3441879 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 702 . 3441633 3441879 206,255,0
chr10 12084983 12085127 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 575 . 12084983 12085127 76,255,0
chr10 12171277 12171424 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 541 . 12171277 12171424 41,255,0
chr10 26986332 26986498 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 593 . 26986332 26986498 94,255,0
chr10 32635643 32635820 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 614 . 32635643 32635820 116,255,0
chr10 39128788 39128940 ID=SRX2537511;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM2476352:%20NRAS%20metastatic%20melanoma%20ChIP-H3K27ac%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K27ac%20(Abcam,%20ab177178); 681 . 39128788 39128940 184,255,0
chr10 39138098 39138241 ID=SRX2537511;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM2476352:%20NRAS%20metastatic%20melanoma%20ChIP-H3K27ac%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K27ac%20(Abcam,%20ab177178); 626 . 39138098 39138241 128,255,0
chr10 39138133 39138276 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 609 . 39138133 39138276 111,255,0
chr10 42398567 42398835 ID=SRX2537511;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM2476352:%20NRAS%20metastatic%20melanoma%20ChIP-H3K27ac%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K27ac%20(Abcam,%20ab177178); 504 . 42398567 42398835 4,255,0
chr10 42398571 42398791 ID=SRX2537505;Name=H3K4me1%20(@%20SK-MEL-2);Title=GSM2476346:%20NRAS%20metastatic%20melanoma%20ChIP-H3K4me1%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K4me1%20(Abcam,%20ab8895); 556 . 42398571 42398791 57,255,0
chr10 42400204 42400708 ID=SRX2537511;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM2476352:%20NRAS%20metastatic%20melanoma%20ChIP-H3K27ac%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K27ac%20(Abcam,%20ab177178); 579 . 42400204 42400708 80,255,0
chr10 42400211 42400701 ID=SRX2537505;Name=H3K4me1%20(@%20SK-MEL-2);Title=GSM2476346:%20NRAS%20metastatic%20melanoma%20ChIP-H3K4me1%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K4me1%20(Abcam,%20ab8895); 524 . 42400211 42400701 24,255,0
chr10 42400222 42400705 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 770 . 42400222 42400705 255,234,0
chr10 42408204 42408363 ID=SRX2537511;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM2476352:%20NRAS%20metastatic%20melanoma%20ChIP-H3K27ac%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K27ac%20(Abcam,%20ab177178); 741 . 42408204 42408363 245,255,0
chr10 42408209 42408355 ID=SRX2537505;Name=H3K4me1%20(@%20SK-MEL-2);Title=GSM2476346:%20NRAS%20metastatic%20melanoma%20ChIP-H3K4me1%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K4me1%20(Abcam,%20ab8895); 621 . 42408209 42408355 123,255,0
chr10 42408211 42408363 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 552 . 42408211 42408363 53,255,0
chr10 42529274 42529614 ID=SRX2537511;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM2476352:%20NRAS%20metastatic%20melanoma%20ChIP-H3K27ac%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K27ac%20(Abcam,%20ab177178); 1000 . 42529274 42529614 255,0,0
chr10 42529279 42529597 ID=SRX2537505;Name=H3K4me1%20(@%20SK-MEL-2);Title=GSM2476346:%20NRAS%20metastatic%20melanoma%20ChIP-H3K4me1%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K4me1%20(Abcam,%20ab8895); 984 . 42529279 42529597 255,16,0
chr10 42529289 42529614 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 887 . 42529289 42529614 255,115,0
chr10 42544667 42544809 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 507 . 42544667 42544809 7,255,0
chr10 42546010 42546156 ID=SRX2537511;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM2476352:%20NRAS%20metastatic%20melanoma%20ChIP-H3K27ac%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K27ac%20(Abcam,%20ab177178); 591 . 42546010 42546156 92,255,0
chr10 42596881 42597192 ID=SRX2537511;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM2476352:%20NRAS%20metastatic%20melanoma%20ChIP-H3K27ac%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K27ac%20(Abcam,%20ab177178); 749 . 42596881 42597192 253,255,0
chr10 42596884 42597186 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 860 . 42596884 42597186 255,142,0
chr10 42596903 42597192 ID=SRX2537505;Name=H3K4me1%20(@%20SK-MEL-2);Title=GSM2476346:%20NRAS%20metastatic%20melanoma%20ChIP-H3K4me1%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K4me1%20(Abcam,%20ab8895); 828 . 42596903 42597192 255,175,0
chr10 42599570 42599874 ID=SRX2537511;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM2476352:%20NRAS%20metastatic%20melanoma%20ChIP-H3K27ac%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K27ac%20(Abcam,%20ab177178); 554 . 42599570 42599874 55,255,0
chr10 42599601 42599960 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 544 . 42599601 42599960 44,255,0
chr10 43133795 43133953 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 611 . 43133795 43133953 113,255,0
chr10 53459466 53459614 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 540 . 53459466 53459614 40,255,0
chr10 69834685 69834875 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 555 . 69834685 69834875 56,255,0
chr10 74114487 74114641 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 668 . 74114487 74114641 171,255,0
chr10 75006791 75006936 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 527 . 75006791 75006936 27,255,0
chr10 76970362 76970513 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 802 . 76970362 76970513 255,201,0
chr10 99078785 99078942 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 754 . 99078785 99078942 255,250,0
chr10 102672777 102673036 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 591 . 102672777 102673036 92,255,0
chr10 102820584 102820732 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 724 . 102820584 102820732 228,255,0
chr10 104614076 104614219 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 523 . 104614076 104614219 23,255,0
chr10 109305662 109305859 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 558 . 109305662 109305859 59,255,0
chr10 120938130 120938275 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 586 . 120938130 120938275 87,255,0
chr10 124739992 124740150 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 637 . 124739992 124740150 139,255,0
chr10 124913958 124914218 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 543 . 124913958 124914218 43,255,0
chr10 126150444 126150590 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 645 . 126150444 126150590 147,255,0
chr10 127511891 127512059 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 850 . 127511891 127512059 255,153,0
chr11 695403 695544 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 514 . 695403 695544 14,255,0
chr11 809314 809456 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 512 . 809314 809456 12,255,0
chr11 809653 809797 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 595 . 809653 809797 96,255,0
chr11 6633620 6633808 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 554 . 6633620 6633808 55,255,0
chr11 6704331 6704501 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 760 . 6704331 6704501 255,244,0
chr11 9406269 9406607 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 507 . 9406269 9406607 7,255,0
chr11 10829824 10830076 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 574 . 10829824 10830076 75,255,0
chr11 18343856 18344013 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 715 . 18343856 18344013 219,255,0
chr11 33060907 33061055 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 530 . 33060907 33061055 30,255,0
chr11 36531625 36531769 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 520 . 36531625 36531769 20,255,0
chr11 43380545 43380698 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 646 . 43380545 43380698 148,255,0
chr11 51579483 51579663 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 546 . 51579483 51579663 46,255,0
chr11 51579487 51579690 ID=SRX2537511;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM2476352:%20NRAS%20metastatic%20melanoma%20ChIP-H3K27ac%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K27ac%20(Abcam,%20ab177178); 866 . 51579487 51579690 255,136,0
chr11 51579500 51579692 ID=SRX2537505;Name=H3K4me1%20(@%20SK-MEL-2);Title=GSM2476346:%20NRAS%20metastatic%20melanoma%20ChIP-H3K4me1%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K4me1%20(Abcam,%20ab8895); 858 . 51579500 51579692 255,144,0
chr11 51582713 51582992 ID=SRX2537511;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM2476352:%20NRAS%20metastatic%20melanoma%20ChIP-H3K27ac%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K27ac%20(Abcam,%20ab177178); 569 . 51582713 51582992 70,255,0
chr11 51582751 51582998 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 600 . 51582751 51582998 102,255,0
chr11 51582763 51582983 ID=SRX2537505;Name=H3K4me1%20(@%20SK-MEL-2);Title=GSM2476346:%20NRAS%20metastatic%20melanoma%20ChIP-H3K4me1%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K4me1%20(Abcam,%20ab8895); 501 . 51582763 51582983 1,255,0
chr11 51586810 51587045 ID=SRX2537511;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM2476352:%20NRAS%20metastatic%20melanoma%20ChIP-H3K27ac%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K27ac%20(Abcam,%20ab177178); 718 . 51586810 51587045 222,255,0
chr11 51586821 51587043 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 714 . 51586821 51587043 218,255,0
chr11 51586826 51587018 ID=SRX2537505;Name=H3K4me1%20(@%20SK-MEL-2);Title=GSM2476346:%20NRAS%20metastatic%20melanoma%20ChIP-H3K4me1%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K4me1%20(Abcam,%20ab8895); 541 . 51586826 51587018 41,255,0
chr11 51588857 51589094 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 788 . 51588857 51589094 255,216,0
chr11 51588859 51589074 ID=SRX2537505;Name=H3K4me1%20(@%20SK-MEL-2);Title=GSM2476346:%20NRAS%20metastatic%20melanoma%20ChIP-H3K4me1%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K4me1%20(Abcam,%20ab8895); 615 . 51588859 51589074 117,255,0
chr11 51588859 51589081 ID=SRX2537511;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM2476352:%20NRAS%20metastatic%20melanoma%20ChIP-H3K27ac%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K27ac%20(Abcam,%20ab177178); 695 . 51588859 51589081 198,255,0
chr11 51590911 51591223 ID=SRX2537511;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM2476352:%20NRAS%20metastatic%20melanoma%20ChIP-H3K27ac%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K27ac%20(Abcam,%20ab177178); 629 . 51590911 51591223 131,255,0
chr11 51590936 51591199 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 520 . 51590936 51591199 20,255,0
chr11 51590970 51591216 ID=SRX2537505;Name=H3K4me1%20(@%20SK-MEL-2);Title=GSM2476346:%20NRAS%20metastatic%20melanoma%20ChIP-H3K4me1%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K4me1%20(Abcam,%20ab8895); 623 . 51590970 51591216 125,255,0
chr11 68924298 68924669 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 522 . 68924298 68924669 22,255,0
chr11 68925121 68925435 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 716 . 68925121 68925435 220,255,0
chr11 69258414 69258606 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 691 . 69258414 69258606 194,255,0
chr11 69489700 69490065 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 679 . 69489700 69490065 182,255,0
chr11 69490358 69490506 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 611 . 69490358 69490506 113,255,0
chr11 70049477 70049992 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 756 . 70049477 70049992 255,248,0
chr11 70116927 70117183 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 702 . 70116927 70117183 206,255,0
chr11 75110629 75110773 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 619 . 75110629 75110773 121,255,0
chr11 75110837 75111074 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 657 . 75110837 75111074 160,255,0
chr12 498540 498682 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 512 . 498540 498682 12,255,0
chr12 1919608 1919917 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 508 . 1919608 1919917 8,255,0
chr12 2113394 2113565 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 660 . 2113394 2113565 163,255,0
chr12 2921883 2922044 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 646 . 2921883 2922044 148,255,0
chr12 6798299 6798476 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 523 . 6798299 6798476 23,255,0
chr12 6862419 6862672 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 542 . 6862419 6862672 42,255,0
chr12 11323853 11324164 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 603 . 11323853 11324164 105,255,0
chr12 12420020 12420179 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 832 . 12420020 12420179 255,171,0
chr12 12940062 12940211 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 552 . 12940062 12940211 53,255,0
chr12 28343439 28343599 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 580 . 28343439 28343599 81,255,0
chr12 51632682 51632925 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 813 . 51632682 51632925 255,190,0
chr12 53400513 53400699 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 627 . 53400513 53400699 129,255,0
chr12 54069668 54069818 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 533 . 54069668 54069818 33,255,0
chr12 56435731 56435874 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 562 . 56435731 56435874 63,255,0
chr12 69979295 69979544 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 695 . 69979295 69979544 198,255,0
chr12 72079901 72080053 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 564 . 72079901 72080053 65,255,0
chr12 77158082 77158236 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 663 . 77158082 77158236 166,255,0
chr12 82752339 82752540 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 975 . 82752339 82752540 255,25,0
chr12 90102907 90103073 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 554 . 90102907 90103073 55,255,0
chr12 93861342 93861488 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 531 . 93861342 93861488 31,255,0
chr12 105501605 105501878 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 540 . 105501605 105501878 40,255,0
chr12 106696351 106696492 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 549 . 106696351 106696492 49,255,0
chr12 110011122 110011270 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 512 . 110011122 110011270 12,255,0
chr12 112279875 112280020 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 534 . 112279875 112280020 34,255,0
chr12 122750764 122750933 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 516 . 122750764 122750933 16,255,0
chr12 123942725 123943047 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 670 . 123942725 123943047 173,255,0
chr12 132195418 132195560 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 563 . 132195418 132195560 64,255,0
chr12 133841540 133841887 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 902 . 133841540 133841887 255,99,0
chr14 20881412 20881575 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 609 . 20881412 20881575 111,255,0
chr14 20923044 20923190 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 584 . 20923044 20923190 85,255,0
chr14 23504239 23504380 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 515 . 23504239 23504380 15,255,0
chr14 23564123 23564279 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 503 . 23564123 23564279 3,255,0
chr14 24025231 24025386 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 575 . 24025231 24025386 76,255,0
chr14 24584012 24584164 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 511 . 24584012 24584164 11,255,0
chr14 24740454 24740655 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 516 . 24740454 24740655 16,255,0
chr14 24911659 24911873 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 503 . 24911659 24911873 3,255,0
chr14 31677150 31677338 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 579 . 31677150 31677338 80,255,0
chr14 35015712 35015882 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 977 . 35015712 35015882 255,23,0
chr14 35025631 35025805 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 978 . 35025631 35025805 255,22,0
chr14 36295669 36295874 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 553 . 36295669 36295874 54,255,0
chr14 39901451 39901594 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 571 . 39901451 39901594 72,255,0
chr14 51707054 51707280 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 543 . 51707054 51707280 43,255,0
chr14 55518432 55518724 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 504 . 55518432 55518724 4,255,0
chr14 67826824 67826973 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 545 . 67826824 67826973 45,255,0
chr14 92588389 92588537 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 515 . 92588389 92588537 15,255,0
chr14 102227516 102227759 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 521 . 102227516 102227759 21,255,0
chr14 103800626 103800901 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 602 . 103800626 103800901 104,255,0
chr15 35838216 35838378 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 548 . 35838216 35838378 48,255,0
chr15 38746420 38746568 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 553 . 38746420 38746568 54,255,0
chr15 40987040 40987212 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 508 . 40987040 40987212 8,255,0
chr15 41408493 41408665 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 991 . 41408493 41408665 255,9,0
chr15 43622595 43622736 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 541 . 43622595 43622736 41,255,0
chr15 52471959 52472105 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 585 . 52471959 52472105 86,255,0
chr15 55488902 55489065 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 589 . 55488902 55489065 90,255,0
chr15 59981285 59981445 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 574 . 59981285 59981445 75,255,0
chr15 65281804 65282091 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 516 . 65281804 65282091 16,255,0
chr15 65596840 65596983 ID=SRX2537511;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM2476352:%20NRAS%20metastatic%20melanoma%20ChIP-H3K27ac%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K27ac%20(Abcam,%20ab177178); 544 . 65596840 65596983 44,255,0
chr15 67813623 67813900 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 619 . 67813623 67813900 121,255,0
chr15 72410748 72410904 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 508 . 72410748 72410904 8,255,0
chr15 75316031 75316271 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 593 . 75316031 75316271 94,255,0
chr15 75932161 75932481 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 543 . 75932161 75932481 43,255,0
chr15 80189513 80189670 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 509 . 80189513 80189670 9,255,0
chr15 83654719 83654880 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 713 . 83654719 83654880 217,255,0
chr16 279223 279391 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 851 . 279223 279391 255,151,0
chr16 771200 771341 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 539 . 771200 771341 39,255,0
chr16 2318221 2318363 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 594 . 2318221 2318363 95,255,0
chr16 2802375 2802534 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 706 . 2802375 2802534 210,255,0
chr16 3030670 3030821 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 571 . 3030670 3030821 72,255,0
chr16 3285253 3285419 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 843 . 3285253 3285419 255,160,0
chr16 3507746 3507887 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 519 . 3507746 3507887 19,255,0
chr16 4233424 4233796 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 640 . 4233424 4233796 142,255,0
chr16 4475574 4475741 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 865 . 4475574 4475741 255,137,0
chr16 10837739 10837892 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 662 . 10837739 10837892 165,255,0
chr16 11945011 11945324 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 595 . 11945011 11945324 96,255,0
chr16 16403394 16403544 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 579 . 16403394 16403544 80,255,0
chr16 19078968 19079120 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 579 . 19078968 19079120 80,255,0
chr16 20752912 20753100 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 586 . 20752912 20753100 87,255,0
chr16 27214851 27215005 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 709 . 27214851 27215005 213,255,0
chr16 28565302 28565458 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 614 . 28565302 28565458 116,255,0
chr16 28874897 28875043 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 643 . 28874897 28875043 145,255,0
chr16 30538265 30538559 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 589 . 30538265 30538559 90,255,0
chr16 30710004 30710280 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 620 . 30710004 30710280 122,255,0
chr16 30934234 30934534 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 532 . 30934234 30934534 32,255,0
chr16 33887603 33887799 ID=SRX2537511;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM2476352:%20NRAS%20metastatic%20melanoma%20ChIP-H3K27ac%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K27ac%20(Abcam,%20ab177178); 990 . 33887603 33887799 255,10,0
chr16 33887612 33887764 ID=SRX2537505;Name=H3K4me1%20(@%20SK-MEL-2);Title=GSM2476346:%20NRAS%20metastatic%20melanoma%20ChIP-H3K4me1%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K4me1%20(Abcam,%20ab8895); 689 . 33887612 33887764 192,255,0
chr16 46723266 46723432 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 790 . 46723266 46723432 255,214,0
chr16 50186857 50187018 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 745 . 50186857 50187018 249,255,0
chr16 58426404 58426665 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 519 . 58426404 58426665 19,255,0
chr16 67217688 67217839 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 573 . 67217688 67217839 74,255,0
chr16 67875980 67876122 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 581 . 67875980 67876122 82,255,0
chr16 68877504 68877648 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 572 . 68877504 68877648 73,255,0
chr16 71495780 71496077 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 564 . 71495780 71496077 65,255,0
chr16 71518297 71518468 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 599 . 71518297 71518468 100,255,0
chr16 74330770 74330986 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 562 . 74330770 74330986 63,255,0
chr16 75182455 75182701 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 788 . 75182455 75182701 255,216,0
chr16 81040575 81040721 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 613 . 81040575 81040721 115,255,0
chr16 87984731 87984883 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 644 . 87984731 87984883 146,255,0
chr16 89753136 89753299 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 754 . 89753136 89753299 255,250,0
chr17 4634775 4634922 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 575 . 4634775 4634922 76,255,0
chr17 19099977 19100153 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 615 . 19099977 19100153 117,255,0
chr17 19266147 19266288 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 580 . 19266147 19266288 81,255,0
chr17 19551496 19551855 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 522 . 19551496 19551855 22,255,0
chr17 19881498 19881670 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 538 . 19881498 19881670 38,255,0
chr17 20092330 20092648 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 529 . 20092330 20092648 29,255,0
chr17 20945907 20946204 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 851 . 20945907 20946204 255,151,0
chr17 33288270 33288414 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 521 . 33288270 33288414 21,255,0
chr17 37617803 37617953 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 509 . 37617803 37617953 9,255,0
chr17 37910248 37910517 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 589 . 37910248 37910517 90,255,0
chr17 40346330 40346473 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 545 . 40346330 40346473 45,255,0
chr17 41381793 41382015 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 521 . 41381793 41382015 21,255,0
chr17 41466055 41466341 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 1000 . 41466055 41466341 255,0,0
chr17 42173240 42173471 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 510 . 42173240 42173471 10,255,0
chr17 42767465 42767645 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 569 . 42767465 42767645 70,255,0
chr17 42976860 42977009 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 738 . 42976860 42977009 242,255,0
chr17 43138735 43138877 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 580 . 43138735 43138877 81,255,0
chr17 44271005 44271317 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 779 . 44271005 44271317 255,225,0
chr17 45000272 45000438 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 906 . 45000272 45000438 255,95,0
chr17 45144665 45144837 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 819 . 45144665 45144837 255,184,0
chr17 46125769 46125917 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 597 . 46125769 46125917 98,255,0
chr17 46178605 46178760 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 555 . 46178605 46178760 56,255,0
chr17 47022306 47022533 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 660 . 47022306 47022533 163,255,0
chr17 47785359 47785514 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 611 . 47785359 47785514 113,255,0
chr17 47866084 47866360 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 958 . 47866084 47866360 255,42,0
chr17 48450336 48450515 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 1000 . 48450336 48450515 255,0,0
chr17 49244161 49244330 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 563 . 49244161 49244330 64,255,0
chr17 49449627 49450033 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 569 . 49449627 49450033 70,255,0
chr17 55162160 55162324 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 733 . 55162160 55162324 237,255,0
chr17 56084101 56084551 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 674 . 56084101 56084551 177,255,0
chr17 57696731 57696902 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 773 . 57696731 57696902 255,231,0
chr17 58156082 58156246 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 815 . 58156082 58156246 255,188,0
chr17 58603347 58603509 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 715 . 58603347 58603509 219,255,0
chr17 60142938 60143254 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 641 . 60142938 60143254 143,255,0
chr17 65362334 65362660 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 892 . 65362334 65362660 255,110,0
chr17 66231551 66231956 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 563 . 66231551 66231956 64,255,0
chr17 66508606 66508747 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 550 . 66508606 66508747 51,255,0
chr17 73042804 73042992 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 660 . 73042804 73042992 163,255,0
chr17 73201590 73201740 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 677 . 73201590 73201740 180,255,0
chr17 73201858 73202026 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 507 . 73201858 73202026 7,255,0
chr17 73663494 73663638 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 512 . 73663494 73663638 12,255,0
chr17 74350078 74350230 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 701 . 74350078 74350230 205,255,0
chr17 74732853 74733288 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 559 . 74732853 74733288 60,255,0
chr17 74733791 74733939 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 522 . 74733791 74733939 22,255,0
chr17 75251930 75252281 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 828 . 75251930 75252281 255,175,0
chr17 76037110 76037320 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 559 . 76037110 76037320 60,255,0
chr17 77770678 77770837 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 503 . 77770678 77770837 3,255,0
chr17 78166309 78166480 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 516 . 78166309 78166480 16,255,0
chr17 79819042 79819184 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 639 . 79819042 79819184 141,255,0
chr17 80376263 80376438 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 840 . 80376263 80376438 255,163,0
chr17 80416148 80416301 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 508 . 80416148 80416301 8,255,0
chr17_gl000205_random 84962 85118 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 507 . 84962 85118 7,255,0
chr17_gl000205_random 86942 87204 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 672 . 86942 87204 175,255,0
chr18 108103 108266 ID=SRX2537511;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM2476352:%20NRAS%20metastatic%20melanoma%20ChIP-H3K27ac%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K27ac%20(Abcam,%20ab177178); 518 . 108103 108266 18,255,0
chr18 2571306 2571456 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 606 . 2571306 2571456 108,255,0
chr18 12884010 12884156 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 552 . 12884010 12884156 53,255,0
chr18 12948055 12948233 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 697 . 12948055 12948233 200,255,0
chr18 12991407 12991559 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 567 . 12991407 12991559 68,255,0
chr18 33647236 33647421 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 551 . 33647236 33647421 52,255,0
chr18 67873014 67873174 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 727 . 67873014 67873174 231,255,0
chr18 77439556 77439707 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 585 . 77439556 77439707 86,255,0
chr19 507549 507768 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 547 . 507549 507768 47,255,0
chr19 892996 893153 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 757 . 892996 893153 255,247,0
chr19 1275595 1275753 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 678 . 1275595 1275753 181,255,0
chr19 1652715 1652874 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 846 . 1652715 1652874 255,157,0
chr19 1848525 1848680 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 757 . 1848525 1848680 255,247,0
chr19 3435042 3435189 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 621 . 3435042 3435189 123,255,0
chr19 3500709 3500862 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 687 . 3500709 3500862 190,255,0
chr19 3626859 3627006 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 670 . 3626859 3627006 173,255,0
chr19 4007277 4007439 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 535 . 4007277 4007439 35,255,0
chr19 5720400 5720544 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 581 . 5720400 5720544 82,255,0
chr19 5790821 5791153 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 685 . 5790821 5791153 188,255,0
chr19 6372847 6373046 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 701 . 6372847 6373046 205,255,0
chr19 8455300 8455506 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 522 . 8455300 8455506 22,255,0
chr19 8578853 8579005 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 672 . 8578853 8579005 175,255,0
chr19 10217081 10217263 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 503 . 10217081 10217263 3,255,0
chr19 10946647 10946823 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 599 . 10946647 10946823 100,255,0
chr19 11708337 11708488 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 639 . 11708337 11708488 141,255,0
chr19 13044152 13044463 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 585 . 13044152 13044463 86,255,0
chr19 14063364 14063506 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 597 . 14063364 14063506 98,255,0
chr19 14640478 14640620 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 526 . 14640478 14640620 26,255,0
chr19 15236304 15236480 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 690 . 15236304 15236480 193,255,0
chr19 16583060 16583225 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 568 . 16583060 16583225 69,255,0
chr19 17622506 17622724 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 517 . 17622506 17622724 17,255,0
chr19 17716909 17717124 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 848 . 17716909 17717124 255,155,0
chr19 19144458 19144603 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 578 . 19144458 19144603 79,255,0
chr19 19303061 19303263 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 638 . 19303061 19303263 140,255,0
chr19 27731957 27732323 ID=SRX2537511;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM2476352:%20NRAS%20metastatic%20melanoma%20ChIP-H3K27ac%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K27ac%20(Abcam,%20ab177178); 858 . 27731957 27732323 255,144,0
chr19 27731964 27732323 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 841 . 27731964 27732323 255,162,0
chr19 27731965 27732320 ID=SRX2537505;Name=H3K4me1%20(@%20SK-MEL-2);Title=GSM2476346:%20NRAS%20metastatic%20melanoma%20ChIP-H3K4me1%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K4me1%20(Abcam,%20ab8895); 884 . 27731965 27732320 255,118,0
chr19 27732610 27732792 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 578 . 27732610 27732792 79,255,0
chr19 27732618 27732783 ID=SRX2537511;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM2476352:%20NRAS%20metastatic%20melanoma%20ChIP-H3K27ac%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K27ac%20(Abcam,%20ab177178); 667 . 27732618 27732783 170,255,0
chr19 27732623 27732775 ID=SRX2537505;Name=H3K4me1%20(@%20SK-MEL-2);Title=GSM2476346:%20NRAS%20metastatic%20melanoma%20ChIP-H3K4me1%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K4me1%20(Abcam,%20ab8895); 592 . 27732623 27732775 93,255,0
chr19 27733105 27733347 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 518 . 27733105 27733347 18,255,0
chr19 27738392 27738659 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 653 . 27738392 27738659 156,255,0
chr19 27738422 27738608 ID=SRX2537511;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM2476352:%20NRAS%20metastatic%20melanoma%20ChIP-H3K27ac%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K27ac%20(Abcam,%20ab177178); 719 . 27738422 27738608 223,255,0
chr19 27738427 27738600 ID=SRX2537505;Name=H3K4me1%20(@%20SK-MEL-2);Title=GSM2476346:%20NRAS%20metastatic%20melanoma%20ChIP-H3K4me1%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K4me1%20(Abcam,%20ab8895); 591 . 27738427 27738600 92,255,0
chr19 37329410 37329554 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 510 . 37329410 37329554 10,255,0
chr19 37708839 37708989 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 668 . 37708839 37708989 171,255,0
chr19 41869884 41870029 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 557 . 41869884 41870029 58,255,0
chr19 42772675 42772821 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 571 . 42772675 42772821 72,255,0
chr19 45982002 45982145 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 521 . 45982002 45982145 21,255,0
chr19 46850419 46850648 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 567 . 46850419 46850648 68,255,0
chr19 47103994 47104150 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 707 . 47103994 47104150 211,255,0
chr19 49588764 49588913 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 522 . 49588764 49588913 22,255,0
chr19 50432461 50432672 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 575 . 50432461 50432672 76,255,0
chr19 52693368 52693513 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 577 . 52693368 52693513 78,255,0
chr19 57049867 57050023 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 619 . 57049867 57050023 121,255,0
chr19 58694482 58694639 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 641 . 58694482 58694639 143,255,0
chr1_gl000192_random 545147 545311 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 697 . 545147 545311 200,255,0
chr2 677211 677372 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 835 . 677211 677372 255,168,0
chr2 20251655 20251796 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 535 . 20251655 20251796 35,255,0
chr2 25016014 25016183 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 1000 . 25016014 25016183 255,0,0
chr2 28113329 28113488 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 653 . 28113329 28113488 156,255,0
chr2 33141282 33141714 ID=SRX2537511;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM2476352:%20NRAS%20metastatic%20melanoma%20ChIP-H3K27ac%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K27ac%20(Abcam,%20ab177178); 1000 . 33141282 33141714 255,0,0
chr2 33141309 33141707 ID=SRX2537505;Name=H3K4me1%20(@%20SK-MEL-2);Title=GSM2476346:%20NRAS%20metastatic%20melanoma%20ChIP-H3K4me1%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K4me1%20(Abcam,%20ab8895); 953 . 33141309 33141707 255,47,0
chr2 38978121 38978430 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 764 . 38978121 38978430 255,240,0
chr2 71558948 71559102 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 590 . 71558948 71559102 91,255,0
chr2 74347519 74347667 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 564 . 74347519 74347667 65,255,0
chr2 74619029 74619182 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 663 . 74619029 74619182 166,255,0
chr2 74667319 74667617 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 531 . 74667319 74667617 31,255,0
chr2 74734629 74734771 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 672 . 74734629 74734771 175,255,0
chr2 75185829 75185983 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 623 . 75185829 75185983 125,255,0
chr2 81708579 81708762 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 547 . 81708579 81708762 47,255,0
chr2 81708932 81709147 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 590 . 81708932 81709147 91,255,0
chr2 85555244 85555393 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 569 . 85555244 85555393 70,255,0
chr2 85766381 85766566 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 582 . 85766381 85766566 83,255,0
chr2 86790132 86790285 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 545 . 86790132 86790285 45,255,0
chr2 92290598 92290761 ID=SRX2537511;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM2476352:%20NRAS%20metastatic%20melanoma%20ChIP-H3K27ac%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K27ac%20(Abcam,%20ab177178); 578 . 92290598 92290761 79,255,0
chr2 92290598 92290765 ID=SRX2537505;Name=H3K4me1%20(@%20SK-MEL-2);Title=GSM2476346:%20NRAS%20metastatic%20melanoma%20ChIP-H3K4me1%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K4me1%20(Abcam,%20ab8895); 651 . 92290598 92290765 154,255,0
chr2 92291417 92291601 ID=SRX2537511;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM2476352:%20NRAS%20metastatic%20melanoma%20ChIP-H3K27ac%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K27ac%20(Abcam,%20ab177178); 749 . 92291417 92291601 253,255,0
chr2 92296818 92296961 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 514 . 92296818 92296961 14,255,0
chr2 95787546 95787714 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 805 . 95787546 95787714 255,198,0
chr2 95831218 95831363 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 559 . 95831218 95831363 60,255,0
chr2 98206560 98206743 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 505 . 98206560 98206743 5,255,0
chr2 105953767 105953908 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 507 . 105953767 105953908 7,255,0
chr2 109336014 109336175 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 612 . 109336014 109336175 114,255,0
chr2 109815804 109816300 ID=SRX2537511;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM2476352:%20NRAS%20metastatic%20melanoma%20ChIP-H3K27ac%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K27ac%20(Abcam,%20ab177178); 973 . 109815804 109816300 255,27,0
chr2 109815814 109816274 ID=SRX2537505;Name=H3K4me1%20(@%20SK-MEL-2);Title=GSM2476346:%20NRAS%20metastatic%20melanoma%20ChIP-H3K4me1%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K4me1%20(Abcam,%20ab8895); 712 . 109815814 109816274 216,255,0
chr2 113033239 113033443 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 538 . 113033239 113033443 38,255,0
chr2 128615484 128615640 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 560 . 128615484 128615640 61,255,0
chr2 153032294 153032438 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 590 . 153032294 153032438 91,255,0
chr2 153574856 153574999 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 576 . 153574856 153574999 77,255,0
chr2 175113561 175113704 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 529 . 175113561 175113704 29,255,0
chr2 178483525 178483678 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 551 . 178483525 178483678 52,255,0
chr2 179315651 179315817 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 822 . 179315651 179315817 255,181,0
chr2 191885334 191885804 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 593 . 191885334 191885804 94,255,0
chr2 201936527 201936674 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 537 . 201936527 201936674 37,255,0
chr2 217277214 217277391 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 724 . 217277214 217277391 228,255,0
chr2 232328978 232329127 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 569 . 232328978 232329127 70,255,0
chr2 232572424 232572650 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 536 . 232572424 232572650 36,255,0
chr2 240323137 240323309 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 1000 . 240323137 240323309 255,0,0
chr2 242640984 242641239 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 512 . 242640984 242641239 12,255,0
chr20 2820944 2821266 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 547 . 2820944 2821266 47,255,0
chr20 3869510 3869694 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 545 . 3869510 3869694 45,255,0
chr20 5100257 5100548 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 734 . 5100257 5100548 238,255,0
chr20 18488225 18488379 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 637 . 18488225 18488379 139,255,0
chr20 25388408 25388589 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 605 . 25388408 25388589 107,255,0
chr20 25604847 25605071 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 516 . 25604847 25605071 16,255,0
chr20 26318422 26318576 ID=SRX2537511;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM2476352:%20NRAS%20metastatic%20melanoma%20ChIP-H3K27ac%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K27ac%20(Abcam,%20ab177178); 621 . 26318422 26318576 123,255,0
chr20 26318423 26318578 ID=SRX2537505;Name=H3K4me1%20(@%20SK-MEL-2);Title=GSM2476346:%20NRAS%20metastatic%20melanoma%20ChIP-H3K4me1%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K4me1%20(Abcam,%20ab8895); 587 . 26318423 26318578 88,255,0
chr20 29829378 29829762 ID=SRX2537511;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM2476352:%20NRAS%20metastatic%20melanoma%20ChIP-H3K27ac%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K27ac%20(Abcam,%20ab177178); 840 . 29829378 29829762 255,163,0
chr20 29829392 29829741 ID=SRX2537505;Name=H3K4me1%20(@%20SK-MEL-2);Title=GSM2476346:%20NRAS%20metastatic%20melanoma%20ChIP-H3K4me1%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K4me1%20(Abcam,%20ab8895); 646 . 29829392 29829741 148,255,0
chr20 30102307 30102566 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 922 . 30102307 30102566 255,79,0
chr20 30262959 30263201 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 534 . 30262959 30263201 34,255,0
chr20 30697338 30697525 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 1000 . 30697338 30697525 255,0,0
chr20 30946130 30946288 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 619 . 30946130 30946288 121,255,0
chr20 31112898 31113078 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 522 . 31112898 31113078 22,255,0
chr20 32251251 32251446 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 541 . 32251251 32251446 41,255,0
chr20 32320166 32320367 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 534 . 32320166 32320367 34,255,0
chr20 32699487 32699968 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 541 . 32699487 32699968 41,255,0
chr20 33264690 33264858 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 678 . 33264690 33264858 181,255,0
chr20 34129904 34130121 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 578 . 34129904 34130121 79,255,0
chr20 34541850 34542153 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 537 . 34541850 34542153 37,255,0
chr20 35807542 35807684 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 567 . 35807542 35807684 68,255,0
chr20 36156351 36156493 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 600 . 36156351 36156493 102,255,0
chr20 37377184 37377340 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 584 . 37377184 37377340 85,255,0
chr20 42086585 42086834 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 950 . 42086585 42086834 255,51,0
chr20 43104576 43104720 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 525 . 43104576 43104720 25,255,0
chr20 43922152 43922488 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 621 . 43922152 43922488 123,255,0
chr20 43991868 43992010 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 536 . 43991868 43992010 36,255,0
chr20 44563069 44563246 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 623 . 44563069 44563246 125,255,0
chr20 44563373 44563591 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 790 . 44563373 44563591 255,214,0
chr20 44600658 44601006 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 801 . 44600658 44601006 255,202,0
chr20 44718359 44718535 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 656 . 44718359 44718535 159,255,0
chr20 44992746 44992993 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 856 . 44992746 44992993 255,146,0
chr20 47662917 47663161 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 583 . 47662917 47663161 84,255,0
chr20 48532123 48532272 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 643 . 48532123 48532272 145,255,0
chr20 52824443 52824624 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 934 . 52824443 52824624 255,67,0
chr20 56175900 56176191 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 556 . 56175900 56176191 57,255,0
chr20 56964447 56964656 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 576 . 56964447 56964656 77,255,0
chr20 57606995 57607330 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 815 . 57606995 57607330 255,188,0
chr20 58515535 58515804 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 608 . 58515535 58515804 110,255,0
chr20 61436210 61436366 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 684 . 61436210 61436366 187,255,0
chr20 62289714 62289858 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 571 . 62289714 62289858 72,255,0
chr20 62886723 62886949 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 557 . 62886723 62886949 58,255,0
chr21 10163955 10164304 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 685 . 10163955 10164304 188,255,0
chr21 10773386 10773575 ID=SRX2537511;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM2476352:%20NRAS%20metastatic%20melanoma%20ChIP-H3K27ac%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K27ac%20(Abcam,%20ab177178); 513 . 10773386 10773575 13,255,0
chr21 10819383 10819718 ID=SRX2537505;Name=H3K4me1%20(@%20SK-MEL-2);Title=GSM2476346:%20NRAS%20metastatic%20melanoma%20ChIP-H3K4me1%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K4me1%20(Abcam,%20ab8895); 971 . 10819383 10819718 255,29,0
chr21 10819390 10819716 ID=SRX2537511;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM2476352:%20NRAS%20metastatic%20melanoma%20ChIP-H3K27ac%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K27ac%20(Abcam,%20ab177178); 1000 . 10819390 10819716 255,0,0
chr21 10819463 10819735 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 961 . 10819463 10819735 255,39,0
chr21 10856755 10856896 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 551 . 10856755 10856896 52,255,0
chr21 19191764 19191908 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 615 . 19191764 19191908 117,255,0
chr21 27107464 27107611 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 544 . 27107464 27107611 44,255,0
chr21 27107741 27107895 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 588 . 27107741 27107895 89,255,0
chr21 30257483 30257641 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 584 . 30257483 30257641 85,255,0
chr21 30397039 30397188 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 612 . 30397039 30397188 114,255,0
chr21 33032062 33032249 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 528 . 33032062 33032249 28,255,0
chr21 37442375 37442613 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 531 . 37442375 37442613 31,255,0
chr21 45358862 45359023 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 541 . 45358862 45359023 41,255,0
chr21 45758214 45758430 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 507 . 45758214 45758430 7,255,0
chr21 48055636 48055798 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 671 . 48055636 48055798 174,255,0
chr22 18348498 18348919 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 511 . 18348498 18348919 11,255,0
chr22 18484347 18484492 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 641 . 18484347 18484492 143,255,0
chr22 18883890 18884092 ID=SRX2537511;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM2476352:%20NRAS%20metastatic%20melanoma%20ChIP-H3K27ac%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K27ac%20(Abcam,%20ab177178); 619 . 18883890 18884092 121,255,0
chr22 19467015 19467178 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 672 . 19467015 19467178 175,255,0
chr22 19842630 19843341 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 547 . 19842630 19843341 47,255,0
chr22 24093423 24093708 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 653 . 24093423 24093708 156,255,0
chr22 24129243 24129447 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 697 . 24129243 24129447 200,255,0
chr22 24666861 24667006 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 600 . 24666861 24667006 102,255,0
chr22 24667139 24667329 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 516 . 24667139 24667329 16,255,0
chr22 30752678 30752836 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 681 . 30752678 30752836 184,255,0
chr22 38349748 38350031 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 504 . 38349748 38350031 4,255,0
chr22 38541322 38541673 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 741 . 38541322 38541673 245,255,0
chr22 38598111 38598395 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 605 . 38598111 38598395 107,255,0
chr22 38901971 38902270 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 640 . 38901971 38902270 142,255,0
chr22 39052441 39052620 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 703 . 39052441 39052620 207,255,0
chr22 39078022 39078173 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 695 . 39078022 39078173 198,255,0
chr22 39716039 39716304 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 530 . 39716039 39716304 30,255,0
chr22 41214790 41215317 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 737 . 41214790 41215317 241,255,0
chr22 41252771 41252934 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 634 . 41252771 41252934 136,255,0
chr22 41347430 41347581 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 733 . 41347430 41347581 237,255,0
chr22 41487820 41488198 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 963 . 41487820 41488198 255,37,0
chr22 41601375 41601798 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 848 . 41601375 41601798 255,155,0
chr22 41716407 41716903 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 563 . 41716407 41716903 64,255,0
chr22 41864484 41864643 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 552 . 41864484 41864643 53,255,0
chr22 41864869 41865018 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 649 . 41864869 41865018 151,255,0
chr22 41865195 41865336 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 509 . 41865195 41865336 9,255,0
chr22 41939975 41940417 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 662 . 41939975 41940417 165,255,0
chr22 42017345 42017683 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 1000 . 42017345 42017683 255,0,0
chr22 42062955 42063387 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 1000 . 42062955 42063387 255,0,0
chr22 42084483 42084790 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 635 . 42084483 42084790 137,255,0
chr22 42085008 42085315 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 651 . 42085008 42085315 154,255,0
chr22 42196073 42196471 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 569 . 42196073 42196471 70,255,0
chr22 42196709 42197013 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 658 . 42196709 42197013 161,255,0
chr22 42229208 42229663 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 563 . 42229208 42229663 64,255,0
chr22 42342975 42343126 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 570 . 42342975 42343126 71,255,0
chr22 42394792 42394984 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 706 . 42394792 42394984 210,255,0
chr22 42467023 42467290 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 817 . 42467023 42467290 255,186,0
chr22 42475755 42475923 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 983 . 42475755 42475923 255,17,0
chr22 42486234 42486717 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 858 . 42486234 42486717 255,144,0
chr22 42765547 42765737 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 545 . 42765547 42765737 45,255,0
chr22 43004611 43004826 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 596 . 43004611 43004826 97,255,0
chr22 43010715 43010867 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 674 . 43010715 43010867 177,255,0
chr22 43112613 43113149 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 515 . 43112613 43113149 15,255,0
chr3 5164049 5164257 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 582 . 5164049 5164257 83,255,0
chr3 9773223 9773368 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 621 . 9773223 9773368 123,255,0
chr3 9932345 9932636 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 731 . 9932345 9932636 235,255,0
chr3 11314166 11314331 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 501 . 11314166 11314331 1,255,0
chr3 11609821 11610001 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 598 . 11609821 11610001 99,255,0
chr3 12598657 12598808 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 539 . 12598657 12598808 39,255,0
chr3 15106454 15106733 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 681 . 15106454 15106733 184,255,0
chr3 15140848 15140990 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 504 . 15140848 15140990 4,255,0
chr3 15247794 15247944 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 503 . 15247794 15247944 3,255,0
chr3 27674450 27674642 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 647 . 27674450 27674642 149,255,0
chr3 28390254 28390456 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 564 . 28390254 28390456 65,255,0
chr3 31573679 31573829 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 595 . 31573679 31573829 96,255,0
chr3 32611941 32612244 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 662 . 32611941 32612244 165,255,0
chr3 33155639 33155901 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 524 . 33155639 33155901 24,255,0
chr3 37217936 37218083 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 501 . 37217936 37218083 1,255,0
chr3 38206765 38206923 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 657 . 38206765 38206923 160,255,0
chr3 41241053 41241223 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 536 . 41241053 41241223 36,255,0
chr3 44379646 44379812 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 748 . 44379646 44379812 252,255,0
chr3 47422588 47422876 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 618 . 47422588 47422876 120,255,0
chr3 47555018 47555174 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 611 . 47555018 47555174 113,255,0
chr3 48130603 48130751 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 549 . 48130603 48130751 49,255,0
chr3 48342552 48342836 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 602 . 48342552 48342836 104,255,0
chr3 48723122 48723299 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 821 . 48723122 48723299 255,182,0
chr3 49044868 49045243 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 622 . 49044868 49045243 124,255,0
chr3 49131295 49131437 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 507 . 49131295 49131437 7,255,0
chr3 49141987 49142132 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 545 . 49141987 49142132 45,255,0
chr3 49157815 49158149 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 568 . 49157815 49158149 69,255,0
chr3 49977625 49977789 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 579 . 49977625 49977789 80,255,0
chr3 50358988 50359147 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 734 . 50358988 50359147 238,255,0
chr3 50388344 50388509 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 876 . 50388344 50388509 255,126,0
chr3 52273309 52273506 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 545 . 52273309 52273506 45,255,0
chr3 52321830 52322017 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 1000 . 52321830 52322017 255,0,0
chr3 52746712 52746990 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 729 . 52746712 52746990 233,255,0
chr3 53381360 53381516 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 667 . 53381360 53381516 170,255,0
chr3 57678507 57678730 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 581 . 57678507 57678730 82,255,0
chr3 57994202 57994469 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 675 . 57994202 57994469 178,255,0
chr3 58292032 58292181 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 551 . 58292032 58292181 52,255,0
chr3 58419357 58419501 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 562 . 58419357 58419501 63,255,0
chr3 64008937 64009090 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 546 . 64008937 64009090 46,255,0
chr3 73159934 73160136 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 949 . 73159934 73160136 255,52,0
chr3 73159958 73160137 ID=SRX2537511;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM2476352:%20NRAS%20metastatic%20melanoma%20ChIP-H3K27ac%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K27ac%20(Abcam,%20ab177178); 727 . 73159958 73160137 231,255,0
chr3 75834310 75834620 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 576 . 75834310 75834620 77,255,0
chr3 84597498 84597846 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 506 . 84597498 84597846 6,255,0
chr3 88199215 88199394 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 555 . 88199215 88199394 56,255,0
chr3 100428429 100428665 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 856 . 100428429 100428665 255,146,0
chr3 101280780 101280944 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 598 . 101280780 101280944 99,255,0
chr3 101395359 101395860 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 533 . 101395359 101395860 33,255,0
chr3 111697916 111698108 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 632 . 111697916 111698108 134,255,0
chr3 112280564 112280720 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 602 . 112280564 112280720 104,255,0
chr3 112280968 112281134 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 624 . 112280968 112281134 126,255,0
chr3 112709878 112710037 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 590 . 112709878 112710037 91,255,0
chr3 119814146 119814433 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 585 . 119814146 119814433 86,255,0
chr3 120461169 120461325 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 630 . 120461169 120461325 132,255,0
chr3 122233568 122233727 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 640 . 122233568 122233727 142,255,0
chr3 123304165 123304313 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 574 . 123304165 123304313 75,255,0
chr3 124449361 124449650 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 504 . 124449361 124449650 4,255,0
chr3 128369331 128369607 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 573 . 128369331 128369607 74,255,0
chr3 128399751 128399909 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 725 . 128399751 128399909 229,255,0
chr3 128902256 128902673 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 639 . 128902256 128902673 141,255,0
chr3 129159241 129159411 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 573 . 129159241 129159411 74,255,0
chr3 130612364 130612701 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 527 . 130612364 130612701 27,255,0
chr3 135915517 135915666 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 544 . 135915517 135915666 44,255,0
chr3 135915826 135915999 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 521 . 135915826 135915999 21,255,0
chr3 135969236 135969385 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 653 . 135969236 135969385 156,255,0
chr3 136581139 136581300 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 547 . 136581139 136581300 47,255,0
chr3 137906196 137906352 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 691 . 137906196 137906352 194,255,0
chr3 140950213 140950429 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 654 . 140950213 140950429 157,255,0
chr3 141457197 141457349 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 512 . 141457197 141457349 12,255,0
chr3 143690655 143690797 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 600 . 143690655 143690797 102,255,0
chr3 155523855 155524009 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 518 . 155523855 155524009 18,255,0
chr3 156272702 156272852 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 553 . 156272702 156272852 54,255,0
chr3 156806698 156806885 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 579 . 156806698 156806885 80,255,0
chr3 158362388 158362563 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 518 . 158362388 158362563 18,255,0
chr3 167452459 167452604 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 597 . 167452459 167452604 98,255,0
chr3 169490920 169491070 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 574 . 169490920 169491070 75,255,0
chr3 169939945 169940102 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 694 . 169939945 169940102 197,255,0
chr3 179280783 179280937 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 712 . 179280783 179280937 216,255,0
chr3 180630518 180630670 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 637 . 180630518 180630670 139,255,0
chr3 183165489 183165667 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 647 . 183165489 183165667 149,255,0
chr3 183735387 183735659 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 633 . 183735387 183735659 135,255,0
chr3 183892727 183892878 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 513 . 183892727 183892878 13,255,0
chr3 184429381 184429720 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 575 . 184429381 184429720 76,255,0
chr3 185655382 185655725 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 915 . 185655382 185655725 255,86,0
chr3 186524382 186524763 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 596 . 186524382 186524763 97,255,0
chr3 193989360 193989626 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 596 . 193989360 193989626 97,255,0
chr3 194991676 194991830 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 663 . 194991676 194991830 166,255,0
chr3 196625606 196625835 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 1000 . 196625606 196625835 255,0,0
chr3 196625624 196625778 ID=SRX2537505;Name=H3K4me1%20(@%20SK-MEL-2);Title=GSM2476346:%20NRAS%20metastatic%20melanoma%20ChIP-H3K4me1%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K4me1%20(Abcam,%20ab8895); 818 . 196625624 196625778 255,185,0
chr3 197025205 197025456 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 587 . 197025205 197025456 88,255,0
chr3 197183271 197183442 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 589 . 197183271 197183442 90,255,0
chr3 197518174 197518345 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 705 . 197518174 197518345 209,255,0
chr4 2010492 2010647 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 581 . 2010492 2010647 82,255,0
chr4 13486082 13486232 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 586 . 13486082 13486232 87,255,0
chr4 40058552 40058752 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 583 . 40058552 40058752 84,255,0
chr4 48833201 48833592 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 523 . 48833201 48833592 23,255,0
chr4 49659538 49659736 ID=SRX2537511;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM2476352:%20NRAS%20metastatic%20melanoma%20ChIP-H3K27ac%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K27ac%20(Abcam,%20ab177178); 745 . 49659538 49659736 249,255,0
chr4 49659561 49659710 ID=SRX2537505;Name=H3K4me1%20(@%20SK-MEL-2);Title=GSM2476346:%20NRAS%20metastatic%20melanoma%20ChIP-H3K4me1%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K4me1%20(Abcam,%20ab8895); 543 . 49659561 49659710 43,255,0
chr4 56212542 56212717 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 640 . 56212542 56212717 142,255,0
chr4 68264731 68264885 ID=SRX2537511;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM2476352:%20NRAS%20metastatic%20melanoma%20ChIP-H3K27ac%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K27ac%20(Abcam,%20ab177178); 539 . 68264731 68264885 39,255,0
chr4 68265442 68265683 ID=SRX2537511;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM2476352:%20NRAS%20metastatic%20melanoma%20ChIP-H3K27ac%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K27ac%20(Abcam,%20ab177178); 754 . 68265442 68265683 255,250,0
chr4 68265464 68265676 ID=SRX2537505;Name=H3K4me1%20(@%20SK-MEL-2);Title=GSM2476346:%20NRAS%20metastatic%20melanoma%20ChIP-H3K4me1%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K4me1%20(Abcam,%20ab8895); 653 . 68265464 68265676 156,255,0
chr4 68265538 68265698 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 634 . 68265538 68265698 136,255,0
chr4 77997236 77997407 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 762 . 77997236 77997407 255,242,0
chr4 90032748 90032900 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 529 . 90032748 90032900 29,255,0
chr4 99916911 99917065 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 638 . 99916911 99917065 140,255,0
chr4 106394732 106394896 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 584 . 106394732 106394896 85,255,0
chr4 108911059 108911243 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 681 . 108911059 108911243 184,255,0
chr4 129474410 129474569 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 509 . 129474410 129474569 9,255,0
chr4 177241202 177241361 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 529 . 177241202 177241361 29,255,0
chr5 52405763 52405904 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 527 . 52405763 52405904 27,255,0
chr5 68513699 68513956 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 535 . 68513699 68513956 35,255,0
chr5 70196583 70196743 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 507 . 70196583 70196743 7,255,0
chr5 75013050 75013208 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 587 . 75013050 75013208 88,255,0
chr5 79950551 79950717 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 592 . 79950551 79950717 93,255,0
chr5 96038607 96038779 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 530 . 96038607 96038779 30,255,0
chr5 96143242 96143586 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 628 . 96143242 96143586 130,255,0
chr5 96143709 96143874 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 500 . 96143709 96143874 0,255,0
chr5 102898279 102898431 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 536 . 102898279 102898431 36,255,0
chr5 107717482 107717705 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 561 . 107717482 107717705 62,255,0
chr5 108063701 108063936 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 608 . 108063701 108063936 110,255,0
chr5 108084157 108084336 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 514 . 108084157 108084336 14,255,0
chr5 110428079 110428338 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 624 . 110428079 110428338 126,255,0
chr5 111496641 111496947 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 505 . 111496641 111496947 5,255,0
chr5 112043326 112043522 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 625 . 112043326 112043522 127,255,0
chr5 115177348 115177508 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 720 . 115177348 115177508 224,255,0
chr5 115420767 115421068 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 587 . 115420767 115421068 88,255,0
chr5 118324016 118324174 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 744 . 118324016 118324174 248,255,0
chr5 118603987 118604225 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 593 . 118603987 118604225 94,255,0
chr5 118788211 118788401 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 797 . 118788211 118788401 255,207,0
chr5 122110828 122111039 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 690 . 122110828 122111039 193,255,0
chr5 123987568 123987730 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 597 . 123987568 123987730 98,255,0
chr5 127419136 127419300 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 691 . 127419136 127419300 194,255,0
chr5 130599835 130600073 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 506 . 130599835 130600073 6,255,0
chr5 131132400 131132627 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 527 . 131132400 131132627 27,255,0
chr5 131629101 131629297 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 533 . 131629101 131629297 33,255,0
chr5 133561421 133561700 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 526 . 133561421 133561700 26,255,0
chr5 134210067 134210341 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 709 . 134210067 134210341 213,255,0
chr5 134735043 134735220 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 505 . 134735043 134735220 5,255,0
chr5 135468609 135468815 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 558 . 135468609 135468815 59,255,0
chr5 137514447 137514588 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 546 . 137514447 137514588 46,255,0
chr5 137673485 137673653 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 1000 . 137673485 137673653 255,0,0
chr5 137673735 137673878 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 596 . 137673735 137673878 97,255,0
chr5 137911184 137911332 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 689 . 137911184 137911332 192,255,0
chr5 138629480 138629987 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 608 . 138629480 138629987 110,255,0
chr5 138677599 138677833 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 744 . 138677599 138677833 248,255,0
chr5 138739561 138739706 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 625 . 138739561 138739706 127,255,0
chr5 138774942 138775152 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 551 . 138774942 138775152 52,255,0
chr5 138897419 138897572 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 516 . 138897419 138897572 16,255,0
chr5 138940350 138940639 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 543 . 138940350 138940639 43,255,0
chr5 139113645 139113900 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 615 . 139113645 139113900 117,255,0
chr5 141303441 141303605 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 696 . 141303441 141303605 199,255,0
chr5 146614251 146614392 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 531 . 146614251 146614392 31,255,0
chr5 149829413 149829559 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 668 . 149829413 149829559 171,255,0
chr5 150080261 150080556 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 793 . 150080261 150080556 255,211,0
chr5 150284613 150284773 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 606 . 150284613 150284773 108,255,0
chr5 150326182 150326329 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 559 . 150326182 150326329 60,255,0
chr5 150460332 150460514 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 530 . 150460332 150460514 30,255,0
chr5 157158473 157158635 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 733 . 157158473 157158635 237,255,0
chr5 157285878 157286081 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 666 . 157285878 157286081 169,255,0
chr5 158690019 158690186 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 668 . 158690019 158690186 171,255,0
chr5 158690363 158690505 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 529 . 158690363 158690505 29,255,0
chr5 159546074 159546366 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 664 . 159546074 159546366 167,255,0
chr5 167913540 167913689 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 529 . 167913540 167913689 29,255,0
chr5 171433709 171433869 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 781 . 171433709 171433869 255,223,0
chr5 173314906 173315082 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 965 . 173314906 173315082 255,35,0
chr5 176778733 176778883 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 597 . 176778733 176778883 98,255,0
chr5 176943743 176943891 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 536 . 176943743 176943891 36,255,0
chr5 179051061 179051485 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 660 . 179051061 179051485 163,255,0
chr5 179105320 179105478 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 601 . 179105320 179105478 103,255,0
chr5 179498914 179499066 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 558 . 179498914 179499066 59,255,0
chr5 180237292 180237439 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 697 . 180237292 180237439 200,255,0
chr5 180287886 180288142 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 621 . 180287886 180288142 123,255,0
chr5 180708422 180708580 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 543 . 180708422 180708580 43,255,0
chr6 3118650 3118800 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 547 . 3118650 3118800 47,255,0
chr6 4776140 4776295 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 651 . 4776140 4776295 154,255,0
chr6 24775228 24775442 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 692 . 24775228 24775442 195,255,0
chr6 30539263 30539416 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 756 . 30539263 30539416 255,248,0
chr6 33679275 33679434 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 819 . 33679275 33679434 255,184,0
chr6 44355480 44355625 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 542 . 44355480 44355625 42,255,0
chr6 61913356 61913528 ID=SRX2537505;Name=H3K4me1%20(@%20SK-MEL-2);Title=GSM2476346:%20NRAS%20metastatic%20melanoma%20ChIP-H3K4me1%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K4me1%20(Abcam,%20ab8895); 818 . 61913356 61913528 255,185,0
chr6 61913370 61913525 ID=SRX2537511;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM2476352:%20NRAS%20metastatic%20melanoma%20ChIP-H3K27ac%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K27ac%20(Abcam,%20ab177178); 661 . 61913370 61913525 164,255,0
chr6 61914148 61914369 ID=SRX2537511;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM2476352:%20NRAS%20metastatic%20melanoma%20ChIP-H3K27ac%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K27ac%20(Abcam,%20ab177178); 606 . 61914148 61914369 108,255,0
chr6 61914195 61914374 ID=SRX2537505;Name=H3K4me1%20(@%20SK-MEL-2);Title=GSM2476346:%20NRAS%20metastatic%20melanoma%20ChIP-H3K4me1%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K4me1%20(Abcam,%20ab8895); 517 . 61914195 61914374 17,255,0
chr6 71276690 71276837 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 559 . 71276690 71276837 60,255,0
chr6 84937455 84937605 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 544 . 84937455 84937605 44,255,0
chr6 86303346 86303516 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 519 . 86303346 86303516 19,255,0
chr6 88182451 88182601 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 549 . 88182451 88182601 49,255,0
chr6 99702702 99702988 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 577 . 99702702 99702988 78,255,0
chr6 137143777 137143925 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 603 . 137143777 137143925 105,255,0
chr6 137540330 137540482 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 617 . 137540330 137540482 119,255,0
chr6 139094661 139094820 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 749 . 139094661 139094820 253,255,0
chr6 143832509 143832791 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 510 . 143832509 143832791 10,255,0
chr6 155054815 155054980 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 508 . 155054815 155054980 8,255,0
chr6 160148199 160148359 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 771 . 160148199 160148359 255,233,0
chr7 807464 807628 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 628 . 807464 807628 130,255,0
chr7 1209423 1209575 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 548 . 1209423 1209575 48,255,0
chr7 2394006 2394147 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 510 . 2394006 2394147 10,255,0
chr7 2595191 2595353 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 804 . 2595191 2595353 255,199,0
chr7 5013713 5013858 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 551 . 5013713 5013858 52,255,0
chr7 5553539 5553754 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 1000 . 5553539 5553754 255,0,0
chr7 6048955 6049107 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 641 . 6048955 6049107 143,255,0
chr7 10979516 10979695 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 542 . 10979516 10979695 42,255,0
chr7 12726548 12726731 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 566 . 12726548 12726731 67,255,0
chr7 22539592 22539739 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 527 . 22539592 22539739 27,255,0
chr7 23221711 23221863 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 525 . 23221711 23221863 25,255,0
chr7 30634550 30634762 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 700 . 30634550 30634762 204,255,0
chr7 32535204 32535388 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 560 . 32535204 32535388 61,255,0
chr7 32997118 32997381 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 618 . 32997118 32997381 120,255,0
chr7 33168622 33168767 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 523 . 33168622 33168767 23,255,0
chr7 40174324 40174478 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 734 . 40174324 40174478 238,255,0
chr7 44613188 44613455 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 587 . 44613188 44613455 88,255,0
chr7 44646246 44646392 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 596 . 44646246 44646392 97,255,0
chr7 44836350 44836506 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 500 . 44836350 44836506 0,255,0
chr7 44836742 44836945 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 515 . 44836742 44836945 15,255,0
chr7 45151063 45151226 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 612 . 45151063 45151226 114,255,0
chr7 61968762 61969629 ID=SRX2537511;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM2476352:%20NRAS%20metastatic%20melanoma%20ChIP-H3K27ac%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K27ac%20(Abcam,%20ab177178); 868 . 61968762 61969629 255,134,0
chr7 61968783 61969627 ID=SRX2537505;Name=H3K4me1%20(@%20SK-MEL-2);Title=GSM2476346:%20NRAS%20metastatic%20melanoma%20ChIP-H3K4me1%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K4me1%20(Abcam,%20ab8895); 815 . 61968783 61969627 255,188,0
chr7 61968789 61969626 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 1000 . 61968789 61969626 255,0,0
chr7 61970243 61970478 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 587 . 61970243 61970478 88,255,0
chr7 61970252 61970483 ID=SRX2537511;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM2476352:%20NRAS%20metastatic%20melanoma%20ChIP-H3K27ac%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K27ac%20(Abcam,%20ab177178); 632 . 61970252 61970483 134,255,0
chr7 61970258 61970479 ID=SRX2537505;Name=H3K4me1%20(@%20SK-MEL-2);Title=GSM2476346:%20NRAS%20metastatic%20melanoma%20ChIP-H3K4me1%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K4me1%20(Abcam,%20ab8895); 586 . 61970258 61970479 87,255,0
chr7 63386520 63386662 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 556 . 63386520 63386662 57,255,0
chr7 66057169 66057312 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 551 . 66057169 66057312 52,255,0
chr7 66385769 66386040 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 747 . 66385769 66386040 251,255,0
chr7 72476096 72476362 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 806 . 72476096 72476362 255,197,0
chr7 72971751 72971898 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 584 . 72971751 72971898 85,255,0
chr7 74072114 74072373 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 504 . 74072114 74072373 4,255,0
chr7 74267473 74267617 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 603 . 74267473 74267617 105,255,0
chr7 74306396 74306626 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 763 . 74306396 74306626 255,241,0
chr7 74489824 74489990 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 503 . 74489824 74489990 3,255,0
chr7 74988539 74988789 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 685 . 74988539 74988789 188,255,0
chr7 76091066 76091220 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 609 . 76091066 76091220 111,255,0
chr7 76589177 76589323 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 601 . 76589177 76589323 103,255,0
chr7 77427379 77427625 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 545 . 77427379 77427625 45,255,0
chr7 86781972 86782132 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 646 . 86781972 86782132 148,255,0
chr7 87563669 87563872 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 573 . 87563669 87563872 74,255,0
chr7 87849462 87849607 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 652 . 87849462 87849607 155,255,0
chr7 91763906 91764048 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 526 . 91763906 91764048 26,255,0
chr7 92219489 92219631 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 521 . 92219489 92219631 21,255,0
chr7 95064126 95064301 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 702 . 95064126 95064301 206,255,0
chr7 95950872 95951282 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 531 . 95950872 95951282 31,255,0
chr7 98923215 98923359 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 507 . 98923215 98923359 7,255,0
chr7 99006319 99006488 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 1000 . 99006319 99006488 255,0,0
chr7 99036629 99036862 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 620 . 99036629 99036862 122,255,0
chr7 99214284 99214445 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 725 . 99214284 99214445 229,255,0
chr7 99746634 99746818 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 648 . 99746634 99746818 150,255,0
chr7 99933789 99933941 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 658 . 99933789 99933941 161,255,0
chr7 100183537 100183712 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 561 . 100183537 100183712 62,255,0
chr7 100209835 100209979 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 541 . 100209835 100209979 41,255,0
chr7 100271148 100271316 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 914 . 100271148 100271316 255,87,0
chr7 100472195 100472512 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 628 . 100472195 100472512 130,255,0
chr7 100728778 100728921 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 503 . 100728778 100728921 3,255,0
chr7 100887756 100887998 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 690 . 100887756 100887998 193,255,0
chr7 100888169 100888332 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 760 . 100888169 100888332 255,244,0
chr7 100965192 100965363 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 665 . 100965192 100965363 168,255,0
chr7 107384288 107384464 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 710 . 107384288 107384464 214,255,0
chr7 107531669 107531824 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 551 . 107531669 107531824 52,255,0
chr7 112430218 112430386 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 678 . 112430218 112430386 181,255,0
chr7 116502686 116502857 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 520 . 116502686 116502857 20,255,0
chr7 120590897 120591064 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 913 . 120590897 120591064 255,88,0
chr7 127983731 127983877 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 590 . 127983731 127983877 91,255,0
chr7 128694694 128694894 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 612 . 128694694 128694894 114,255,0
chr7 128695034 128695182 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 549 . 128695034 128695182 49,255,0
chr7 129251272 129251438 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 617 . 129251272 129251438 119,255,0
chr7 132766613 132766785 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 572 . 132766613 132766785 73,255,0
chr7 132937906 132938050 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 525 . 132937906 132938050 25,255,0
chr7 138916041 138916217 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 518 . 138916041 138916217 18,255,0
chr7 139026111 139026400 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 780 . 139026111 139026400 255,224,0
chr7 139044231 139044408 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 614 . 139044231 139044408 116,255,0
chr7 139044721 139044924 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 625 . 139044721 139044924 127,255,0
chr7 140396782 140396935 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 508 . 140396782 140396935 8,255,0
chr7 140714554 140714697 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 551 . 140714554 140714697 52,255,0
chr7 141438220 141438388 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 670 . 141438220 141438388 173,255,0
chr7 142960607 142960754 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 519 . 142960607 142960754 19,255,0
chr7 143599070 143599215 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 582 . 143599070 143599215 83,255,0
chr7 144533311 144533522 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 502 . 144533311 144533522 2,255,0
chr7 154794896 154795041 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 649 . 154794896 154795041 151,255,0
chr7_gl000195_random 30973 31167 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 683 . 30973 31167 186,255,0
chr7_gl000195_random 31540 31774 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 827 . 31540 31774 255,176,0
chr7_gl000195_random 32124 32392 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 809 . 32124 32392 255,194,0
chr7_gl000195_random 86445 86589 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 504 . 86445 86589 4,255,0
chr7_gl000195_random 138050 138392 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 1000 . 138050 138392 255,0,0
chr8 21867953 21868231 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 502 . 21867953 21868231 2,255,0
chr8 25316508 25316664 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 741 . 25316508 25316664 245,255,0
chr8 42698202 42698394 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 566 . 42698202 42698394 67,255,0
chr8 43092864 43093116 ID=SRX2537511;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM2476352:%20NRAS%20metastatic%20melanoma%20ChIP-H3K27ac%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K27ac%20(Abcam,%20ab177178); 637 . 43092864 43093116 139,255,0
chr8 43092867 43093039 ID=SRX2537505;Name=H3K4me1%20(@%20SK-MEL-2);Title=GSM2476346:%20NRAS%20metastatic%20melanoma%20ChIP-H3K4me1%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K4me1%20(Abcam,%20ab8895); 648 . 43092867 43093039 150,255,0
chr8 43094763 43094917 ID=SRX2537511;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM2476352:%20NRAS%20metastatic%20melanoma%20ChIP-H3K27ac%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K27ac%20(Abcam,%20ab177178); 644 . 43094763 43094917 146,255,0
chr8 43094765 43094919 ID=SRX2537505;Name=H3K4me1%20(@%20SK-MEL-2);Title=GSM2476346:%20NRAS%20metastatic%20melanoma%20ChIP-H3K4me1%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K4me1%20(Abcam,%20ab8895); 605 . 43094765 43094919 107,255,0
chr8 82598329 82598474 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 545 . 82598329 82598474 45,255,0
chr8 96281566 96281781 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 552 . 96281566 96281781 53,255,0
chr8 104427138 104427294 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 500 . 104427138 104427294 0,255,0
chr8 117925482 117925657 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 524 . 117925482 117925657 24,255,0
chr8 145133664 145133941 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 558 . 145133664 145133941 59,255,0
chr9 17135073 17135401 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 572 . 17135073 17135401 73,255,0
chr9 26892529 26892700 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 534 . 26892529 26892700 34,255,0
chr9 34049012 34049156 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 545 . 34049012 34049156 45,255,0
chr9 35072381 35072546 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 610 . 35072381 35072546 112,255,0
chr9 35096309 35096532 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 577 . 35096309 35096532 78,255,0
chr9 37784832 37784985 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 518 . 37784832 37784985 18,255,0
chr9 42819053 42819218 ID=SRX2537511;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM2476352:%20NRAS%20metastatic%20melanoma%20ChIP-H3K27ac%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K27ac%20(Abcam,%20ab177178); 701 . 42819053 42819218 205,255,0
chr9 42819088 42819230 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 573 . 42819088 42819230 74,255,0
chr9 66458144 66458428 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 556 . 66458144 66458428 57,255,0
chr9 66833070 66833219 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 581 . 66833070 66833219 82,255,0
chr9 66833787 66833947 ID=SRX2537511;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM2476352:%20NRAS%20metastatic%20melanoma%20ChIP-H3K27ac%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K27ac%20(Abcam,%20ab177178); 668 . 66833787 66833947 171,255,0
chr9 66971017 66971409 ID=SRX2537511;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM2476352:%20NRAS%20metastatic%20melanoma%20ChIP-H3K27ac%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K27ac%20(Abcam,%20ab177178); 1000 . 66971017 66971409 255,0,0
chr9 66971019 66971388 ID=SRX2537505;Name=H3K4me1%20(@%20SK-MEL-2);Title=GSM2476346:%20NRAS%20metastatic%20melanoma%20ChIP-H3K4me1%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K4me1%20(Abcam,%20ab8895); 947 . 66971019 66971388 255,54,0
chr9 66971027 66971365 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 834 . 66971027 66971365 255,169,0
chr9 67320485 67320930 ID=SRX2537505;Name=H3K4me1%20(@%20SK-MEL-2);Title=GSM2476346:%20NRAS%20metastatic%20melanoma%20ChIP-H3K4me1%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K4me1%20(Abcam,%20ab8895); 899 . 67320485 67320930 255,103,0
chr9 67320485 67320933 ID=SRX2537511;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM2476352:%20NRAS%20metastatic%20melanoma%20ChIP-H3K27ac%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K27ac%20(Abcam,%20ab177178); 1000 . 67320485 67320933 255,0,0
chr9 67320525 67320922 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 815 . 67320525 67320922 255,188,0
chr9 68726041 68726262 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 674 . 68726041 68726262 177,255,0
chr9 69710883 69711313 ID=SRX2537511;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM2476352:%20NRAS%20metastatic%20melanoma%20ChIP-H3K27ac%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K27ac%20(Abcam,%20ab177178); 1000 . 69710883 69711313 255,0,0
chr9 69710896 69711292 ID=SRX2537505;Name=H3K4me1%20(@%20SK-MEL-2);Title=GSM2476346:%20NRAS%20metastatic%20melanoma%20ChIP-H3K4me1%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K4me1%20(Abcam,%20ab8895); 1000 . 69710896 69711292 255,0,0
chr9 69710916 69711232 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 729 . 69710916 69711232 233,255,0
chr9 70076669 70076830 ID=SRX2537511;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM2476352:%20NRAS%20metastatic%20melanoma%20ChIP-H3K27ac%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K27ac%20(Abcam,%20ab177178); 651 . 70076669 70076830 154,255,0
chr9 70327410 70327564 ID=SRX2537511;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM2476352:%20NRAS%20metastatic%20melanoma%20ChIP-H3K27ac%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K27ac%20(Abcam,%20ab177178); 675 . 70327410 70327564 178,255,0
chr9 86322639 86322804 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 541 . 86322639 86322804 41,255,0
chr9 86322965 86323109 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 535 . 86322965 86323109 35,255,0
chr9 95087983 95088137 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 670 . 95087983 95088137 173,255,0
chr9 98079707 98079909 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 604 . 98079707 98079909 106,255,0
chr9 98638007 98638176 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 677 . 98638007 98638176 180,255,0
chr9 100684586 100684742 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 572 . 100684586 100684742 73,255,0
chr9 101018171 101018322 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 525 . 101018171 101018322 25,255,0
chr9 107730655 107730802 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 600 . 107730655 107730802 102,255,0
chr9 110045607 110045758 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 656 . 110045607 110045758 159,255,0
chr9 130565225 130565373 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 608 . 130565225 130565373 110,255,0
chr9 131084869 131085051 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 902 . 131084869 131085051 255,99,0
chr9 131419122 131419286 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 738 . 131419122 131419286 242,255,0
chr9 132586195 132586358 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 661 . 132586195 132586358 164,255,0
chr9 136325153 136325307 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 621 . 136325153 136325307 123,255,0
chr9 139378028 139378194 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 507 . 139378028 139378194 7,255,0
chr9 140118226 140118367 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 503 . 140118226 140118367 3,255,0
chr9_gl000199_random 34366 34567 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 658 . 34366 34567 161,255,0
chr9_gl000199_random 34372 34545 ID=SRX2537511;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM2476352:%20NRAS%20metastatic%20melanoma%20ChIP-H3K27ac%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K27ac%20(Abcam,%20ab177178); 795 . 34372 34545 255,209,0
chr9_gl000199_random 34378 34558 ID=SRX2537505;Name=H3K4me1%20(@%20SK-MEL-2);Title=GSM2476346:%20NRAS%20metastatic%20melanoma%20ChIP-H3K4me1%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K4me1%20(Abcam,%20ab8895); 839 . 34378 34558 255,164,0
chrUn_gl000212 40783 40936 ID=SRX2537505;Name=H3K4me1%20(@%20SK-MEL-2);Title=GSM2476346:%20NRAS%20metastatic%20melanoma%20ChIP-H3K4me1%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K4me1%20(Abcam,%20ab8895); 639 . 40783 40936 141,255,0
chrUn_gl000212 40786 40937 ID=SRX2537511;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM2476352:%20NRAS%20metastatic%20melanoma%20ChIP-H3K27ac%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K27ac%20(Abcam,%20ab177178); 598 . 40786 40937 99,255,0
chrUn_gl000214 30445 30776 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 611 . 30445 30776 113,255,0
chrUn_gl000216 75695 76022 ID=SRX2537505;Name=H3K4me1%20(@%20SK-MEL-2);Title=GSM2476346:%20NRAS%20metastatic%20melanoma%20ChIP-H3K4me1%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K4me1%20(Abcam,%20ab8895); 557 . 75695 76022 58,255,0
chrUn_gl000216 75739 76060 ID=SRX2537511;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM2476352:%20NRAS%20metastatic%20melanoma%20ChIP-H3K27ac%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K27ac%20(Abcam,%20ab177178); 675 . 75739 76060 178,255,0
chrUn_gl000216 145176 145352 ID=SRX2537511;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM2476352:%20NRAS%20metastatic%20melanoma%20ChIP-H3K27ac%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K27ac%20(Abcam,%20ab177178); 562 . 145176 145352 63,255,0
chrUn_gl000220 6977 7199 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 624 . 6977 7199 126,255,0
chrUn_gl000220 7461 7754 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 1000 . 7461 7754 255,0,0
chrUn_gl000220 7948 8193 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 648 . 7948 8193 150,255,0
chrUn_gl000220 104305 104490 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 1000 . 104305 104490 255,0,0
chrUn_gl000220 148296 148451 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 746 . 148296 148451 250,255,0
chrUn_gl000221 79738 79943 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 761 . 79738 79943 255,243,0
chrX 1510749 1510927 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 505 . 1510749 1510927 5,255,0
chrX 62571009 62571151 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 549 . 62571009 62571151 49,255,0
chrX 67718591 67718752 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 501 . 67718591 67718752 1,255,0
chrX 100603836 100603995 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 714 . 100603836 100603995 218,255,0
chrX 102942224 102942367 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 561 . 102942224 102942367 62,255,0
chrX 103401482 103401623 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 517 . 103401482 103401623 17,255,0
chrX 108780113 108780276 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 767 . 108780113 108780276 255,237,0
chrX 110924449 110924694 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 657 . 110924449 110924694 160,255,0
chrX 114960662 114960814 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 570 . 114960662 114960814 71,255,0
chrX 118602460 118602603 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 561 . 118602460 118602603 62,255,0
chrX 118740129 118740322 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 639 . 118740129 118740322 141,255,0
chrX 153059626 153059784 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 733 . 153059626 153059784 237,255,0
chrX 155260049 155260356 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 644 . 155260049 155260356 146,255,0
chrY 13801031 13801211 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 657 . 13801031 13801211 160,255,0
chrY 13842611 13842829 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 1000 . 13842611 13842829 255,0,0
chrY 13842616 13842843 ID=SRX2537511;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM2476352:%20NRAS%20metastatic%20melanoma%20ChIP-H3K27ac%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K27ac%20(Abcam,%20ab177178); 1000 . 13842616 13842843 255,0,0
chrY 13842617 13842839 ID=SRX2537505;Name=H3K4me1%20(@%20SK-MEL-2);Title=GSM2476346:%20NRAS%20metastatic%20melanoma%20ChIP-H3K4me1%20[SKmel2]%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Cell%20culture;cell%20line=SKmel2;passage=N/A;antibodies=H3K4me1%20(Abcam,%20ab8895); 1000 . 13842617 13842839 255,0,0
chrY 13868324 13868510 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 641 . 13868324 13868510 143,255,0
chrY 59363043 59363373 ID=SRX1451226;Name=H3K27ac%20(@%20SK-MEL-2);Title=GSM1953840:%20SKMEL2%20H3K27Ac%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=human%20melanoma%20cell%20lines;cell%20line=SKMEL2;cell%20type=melanoma;passages=long%20term%20culture;chip%20antibody=H3K27Ac%20(ab4729)%20(Abcam); 842 . 59363043 59363373 255,161,0